1. Societe D'etude Et De Recherche En Ingenierie Pharmaceutique Seripharm (5 from 5 patents)

2. Stragen Pharma Sa (4 from 6 patents)

3. Pierre Fabre Medicament (3 from 266 patents)

4. Oncopharm Corporation (2 from 2 patents)

5. Novasep (1 from 8 patents)

6. Chemgenex Pharmaceuticals, Inc. (1 from 4 patents)

7. Universite Du Maine (le Mans) (1 from 3 patents)

1. 7842687 - Cephalotaxane derivatives and their processes of preparation and purification

2. 7432383 - Intermediates for the hemisynthesis of taxanes and preparation processes therefor

3. 7285546 - Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents

4. 7279586 - Intermediates for the hemisynthesis of taxanes and preparation processes therefor

5. 7220871 - Intermediates for the hemisynthesis of taxanes and preparation processes therefor

6. 7169774 - Cephalotaxane derivatives and their processes of preparation and purification

7. 6987103 - Treatment of chronic myelogenous leukmia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agents

8. 6831180 - Cephalotaxane derivatives and process for their preparation

9. 6825365 - Intermediates for the hemisynthesis of taxanes and preparation processes therefor

10. 6613900 - Cephalotaxane derivatives and process for their preparation

11. 6579869 - Cephalotaxanes: their method of preparation and their use in treatment of cancers, leukemias, parasites, including those resistant to usual chemotherapeutic agents, and as reversal agents

12. 6265587 - Intermediary compounds for the hemisynthesis of taxanes and preparation processes therefor

13. 6180802 - Method for selective protection of baccatin derivatives and its application to taxane synthesis

14. 6107284 - Water-soluble derivatives of epipodophyllotoxin, process for their

15. 5643885 - Etoposide derivatives, process for preparing them, their use as a